| 摘要 |
<p>Renin inhibitory peptides of the formula <CHEM> are disclosed wherein: A is, e.g., hydrogen; B is., e g., absent or glycyl; D is absent; or <CHEM> where Z is (CH2)n and n is 1 or 2; or -S-; R<1>, R<2> and R<4> are, e.g., hydrogen; R<3>, is, e.g., C3-6 alkyl; E is, e.g., -Y-(CH2)n-H where Y is -NH- or -O-; and n is 0 to 5; wherein all of the asymmetric carbon atoms have an S configuration, except for those in the B, D and E substituents, which may have an S or R configuration and a pharmaceutically acceptable salt thereof. Those peptides are useful for treating various forms of renin-associated hypertension and hyperaldosteronism.</p> |
